


Healthcare News Roundup: Drug Delivery
HSMN NewsFeed - 24 Apr 2012
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
